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Sounding the Alarm: Multiple 
Functions of Host Defense Peptides
Richard L. Gallo1
The capacity of the skin and other organs to resist infection depends on the innate 
production of molecules known as antimicrobial peptides. Emerging evidence 
suggests that some of these peptides are important to immune defense by act-
ing not only as natural antibiotics but also as cell-signaling molecules. In this issue 
Carretero et al. (2007) expand on these findings by demonstrating that expression 
of human cathelicidin alters multiple signaling pathways in a keratinocyte cell line 
and enhances wound re-epithelialization in ob/ob mice.
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Microbes are a formidable adversary 
for all epithelial barriers and have 
evolved a wide variety of mechanisms 
to invade the skin and induce disease. 
These virulence factors necessitate that 
the host use multiple defense strate-
gies for protection. The physical barrier 
provided by the epidermis is essential, 
but many microbes have evolved effec-
tive systems to breach the epidermis. 
Similarly, the recruitment of circulat-
ing immune effector cells is also an 
absolute requirement for adequate 
protection against infection, but many 
pathogens have evolved systems to 
evade the cellular immune system. In 
addition, all microbes proliferate too 
rapidly to be effectively controlled by 
the relatively slow inflammatory pro-
cess alone. The answer to this problem 
is the relatively recently recognized sys-
tems for the generation of antimicrobial 
molecules by the epidermis. In particu-
lar, the production of peptides with anti-
microbial activity has been shown to 
be essential for normal defense against 
microbial infection, providing a rapid, 
first-line chemical barrier to inhibit 
microbial growth (Zasloff, 2002).
Research such as that described by 
Carretero et al. (2007) is expanding our 
understanding of antimicrobial pep-
tides (AMPs) to show that some of these 
host-defense peptides exert their effect 
not only through their capacity to act 
as an antibiotic but also by their abil-
ity to alert the host and stimulate many 
elements of the defense system, includ-
ing barrier repair and inflammatory 
cell recruitment. These activities have 
inspired the use of the term “alarm-
ins” (Oppenheim and Yang, 2005) to 
describe some AMPs.
AMPs were first described in the 
1970s and 1980s as gene-encoded 
molecules responsible for disease resis-
tance in plants and insects. Later, with 
the identification of defensins in neutro-
phil granules, it became clear that simi-
lar peptides might also be important to 
the mammalian immune system. As the 
more complex immune defense systems 
of mammals have been described, the 
apparent role of AMPs in host defense 
has continued to expand. In fact, our 
initial discovery of AMPs in the skin was 
made not because of their capacity to 
kill microbes but because of the abil-
ity of some of these peptides to induce 
the expression of syndecan-1 and -4 in 
fibroblasts (Gallo et al., 1994). This event 
is critical to the wound-repair process.
Overwhelming evidence now exists 
that the AMPs have many distinct and 
complementary functions. When these 
functions are disrupted by abnormal 
expression, human disease can result. 
Examples of this include atopic derma-
titis, which shows decreased expres-
sion of multiple AMPs and an increased 
susceptibility to infections (Ong et al., 
2002), and rosacea, which has exces-
sive and abnormally processed cat-
helicidin peptides that will reproduce 
elements of the disease in mice 
(Yamasaki et al., 2007) How these pro-
cesses are regulated is an area of ongo-
ing investigation. However, progress 
has been made in understanding how 
specific AMPs can influence host-cell 
responses. The human cathelicidin 
peptide LL-37 has been shown to acti-
vate mitogen-activated protein kinase 
(MAPK) and extracellular signal-related 
kinase in epithelial cells (Tjabringa et 
al., 2003), and blocking antibodies to 
LL-37 hinder wound repair in human 
skin equivalents (Heilborn et al., 2003). 
In this issue Carretero et al. (2007) pro-
vide further evidence that cathelicidin 
participates in the process of epitheli-
alization by demonstrating that overex-
pression accelerates migration of HaCat 
in vitro and mouse skin re-epitheli-
alization in vivo. Adenoviral-mediated 
expression of this cathelicidin altered 
multiple signaling pathways, including 
both MAPK and PI-3K. Such effects are 
consistent with observations in many 
experimental systems that have shown 
that AMPs can trigger a set of events 
specific to the cell type of interest. 
The mechanism responsible for these 
responses is unclear. As illustrated in 
Figure 1, there are data to support sev-
eral systems by which AMPs could stim-
ulate host-cell responses. These include 
binding to a specific receptor, transacti-
vation of a receptor, or specific changes 
to the cell membrane that result in an 
alteration in the overall pattern of activ-
ity of membrane-associated signaling 
molecules. The latter hypothesis implies 
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that responses to AMPs are controlled 
in part by the composition of the cell 
membrane (Di Nardo et al., 2007).
Although it is clear that the AMPs 
have an important role to play in skin 
biology, progress in understanding 
the functions of AMPs and in develop-
ing therapies based on these naturally 
occurring molecules has been hindered 
by an unfortunate tendency to lump 
the many diverse peptides and proteins 
with antimicrobial activity into a single 
conceptual category. Unfortunately, 
because of this tendency, it is frequently 
and incorrectly assumed that a function 
seen in one peptide should be applied 
to another. It is inappropriate to com-
pare these greatly diverse peptides to 
make conclusions regarding their rela-
tive role or to expect that a drug design 
based on the ability of an AMP to kill 
bacteria will retain its important effects 
on the host. In fact, confusion regard-
ing the native peptides is common. For 
example, the important and excellent 
work by Carretero et al. in this issue is 
somewhat limited by their choice of an 
expression vector that was designed to 
overexpress the full-length precursor 
protein of cathelicidin (hCAP18). Unlike 
what is implied by the title of this article, 
it is not clear whether the peptide LL-37 
is actually present and responsible for 
the effects observed. hCAP18 can be 
enzymatically processed into multiple 
alternative forms with different functions 
(Braff et al., 2005b).
We now know of more than 20 AMPs 
in the skin, including cathelicidins, β-
defensins, Substance P, RANTES, RNase 
2,3,7, S100A7, and several others (Braff 
et al., 2005a). Many peptides have anti-
microbial action against bacteria, viru-
ses, and fungi. Some may play a specific 
role against certain microbes in normal 
skin, whereas others act only when the 
skin is injured and the physical bar-
rier disrupted. Some other peptides may 
play a larger role to signal host respons-
es through chemotactic, angiogenic, 
growth factor, and immunosuppressive 
activity. The full functions of these evo-
lutionarily ancient classes of molecules 
are slowly being uncovered. Stay tuned.
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Figure 1 Alternative models for cell activation by antimicrobial peptides. Antimicrobial peptides such 
as LL-37 are typically small and cationic and can interact with hydrophobic membranes. Three major 
mechanisms have been proposed to explain how LL-37 activates mammalian cells. In the transactivation 
model, LL-37 stimulates the release of a membrane-bound growth factor. This then binds its high-
affinity receptor and activates it. In the receptor-binding model, LL-37 serves as a surrogate ligand for 
a specific receptor. This direct binding initiates receptor activation. In the receptor-activation model, 
LL-37 associates with and modifies the membrane containing the receptor. This membrane activity 
indirectly results in a change in receptor function such that it can signal without a ligand or becomes 
insensitive to binding by its specific ligand. Evidence to support the transactivation model has been 
reported in keratinocytes and pulmonary epithelial cells; receptor binding is supported in monocytes 
and endothelia, and receptor activation in dendritic cells.
